124 related articles for article (PubMed ID: 1349879)
1. Dexmedetomidine-induced ocular hypotension in rabbits with normal or elevated intraocular pressures.
Vartiainen J; MacDonald E; Urtti A; Rouhiainen H; Virtanen R
Invest Ophthalmol Vis Sci; 1992 May; 33(6):2019-23. PubMed ID: 1349879
[TBL] [Abstract][Full Text] [Related]
2. Medetomidine-induced alterations of intraocular pressure and contraction of the nictitating membrane.
Potter DE; Ogidigben MJ
Invest Ophthalmol Vis Sci; 1991 Sep; 32(10):2799-805. PubMed ID: 1680113
[TBL] [Abstract][Full Text] [Related]
3. Fadolmidine-induced ocular hypotension in normotensive rabbits.
Savolainen J; Niemi R; Mäntylä A; Huuskonen J; Järvinen T
J Pharm Pharmacol; 2005 Feb; 57(2):191-5. PubMed ID: 15720782
[TBL] [Abstract][Full Text] [Related]
4. Ocular hypotensive effects of medetomidine and its analogs.
Jin Y; Wilson S; Elko EE; Yorio T
J Ocul Pharmacol; 1991; 7(4):285-96. PubMed ID: 1687323
[TBL] [Abstract][Full Text] [Related]
5. Naphazoline-induced suppression of aqueous humor pressure and flow: involvement of central and peripheral alpha(2)/I(1) receptors.
Ogidigben MJ; Chu TC; Potter DE
Exp Eye Res; 2001 Mar; 72(3):331-9. PubMed ID: 11180982
[TBL] [Abstract][Full Text] [Related]
6. 8OH-DPAT-Induced ocular hypotension: sites and mechanisms of action.
Chu TC; Ogidigben MJ; Potter DE
Exp Eye Res; 1999 Aug; 69(2):227-38. PubMed ID: 10433858
[TBL] [Abstract][Full Text] [Related]
7. The effect of the H-1152P, a potent Rho-associated coiled coil-formed protein kinase inhibitor, in rabbit normal and ocular hypertensive eyes.
Nishio M; Fukunaga T; Sugimoto M; Ikesugi K; Sumi K; Hidaka H; Uji Y
Curr Eye Res; 2009 Apr; 34(4):282-6. PubMed ID: 19373576
[TBL] [Abstract][Full Text] [Related]
8. Comparative effects of alpha-2 and DA-2 agonists on intraocular pressure in pigmented and nonpigmented rabbits.
Ogidigben MJ; Potter DE
J Ocul Pharmacol; 1993; 9(3):187-99. PubMed ID: 7901309
[TBL] [Abstract][Full Text] [Related]
9. Ocular actions of moxonidine: a possible role for imidazoline receptors.
Ogidigben M; Chu TC; Potter DE
J Pharmacol Exp Ther; 1994 Jun; 269(3):897-904. PubMed ID: 7912282
[TBL] [Abstract][Full Text] [Related]
10. Topical application of a cyclic GMP analog lowers IOP in normal and ocular hypertensive rabbits.
Stein PJ; Clack JW
Invest Ophthalmol Vis Sci; 1994 May; 35(6):2765-8. PubMed ID: 8188470
[TBL] [Abstract][Full Text] [Related]
11. Ocular hypotensive activity of pirbuterol eye drops in rabbits.
Bonomi L; Perfetti S; Bellucci R; De Franco I
J Ocul Pharmacol; 1991; 7(3):191-4. PubMed ID: 1686050
[TBL] [Abstract][Full Text] [Related]
12. Ocular hypotensive action of a dopaminergic (DA2) agonist, 2,10,11-trihydroxy-N-n-propylnoraporphine.
Ogidigben M; Chu TC; Potter DE
J Pharmacol Exp Ther; 1993 Nov; 267(2):822-7. PubMed ID: 7902435
[TBL] [Abstract][Full Text] [Related]
13. The effect of topical diltiazem on the intraocular pressure in betamethasone-induced ocular hypertensive rabbits.
Melena J; Santafé J; Segarra J
J Pharmacol Exp Ther; 1998 Jan; 284(1):278-82. PubMed ID: 9435188
[TBL] [Abstract][Full Text] [Related]
14. [Effects of pilocarpine in new ophthalmic formulations on intraocular pressure in rabbits with ocular hypertension].
Xu Y; Chen Z; Song J
Zhonghua Yan Ke Za Zhi; 2002 Dec; 38(12):721-4. PubMed ID: 12654220
[TBL] [Abstract][Full Text] [Related]
15. Ocular hypotensive and aqueous outflow-enhancing effects of AL-3037A (sodium ferri ethylenediaminetetraacetate).
Pang IH; Moll H; McLaughlin MA; Knepper PA; De Santis L; Epstein DL; Clark AF
Exp Eye Res; 2001 Dec; 73(6):815-25. PubMed ID: 11846512
[TBL] [Abstract][Full Text] [Related]
16. Ophthalmic arachidonylethanolamide decreases intraocular pressure in normotensive rabbits.
Pate DW; Järvinen K; Urtti A; Jarho P; Järvinen T
Curr Eye Res; 1995 Sep; 14(9):791-7. PubMed ID: 8529418
[TBL] [Abstract][Full Text] [Related]
17. Apraclonidine and brimonidine effects on anterior ocular and cardiovascular physiology in normal and sympathectomized monkeys.
Gabelt BT; Robinson JC; Hubbard WC; Peterson CM; Debink N; Wadhwa A; Kaufman PL
Exp Eye Res; 1994 Dec; 59(6):633-44. PubMed ID: 7698258
[TBL] [Abstract][Full Text] [Related]
18. Modulation of ocular hydrodynamics and iris function by bremazocine, a kappa opioid receptor agonist.
Russell KR; Wang DR; Potter DE
Exp Eye Res; 2000 May; 70(5):675-82. PubMed ID: 10870526
[TBL] [Abstract][Full Text] [Related]
19. Neuroprotection of retinal ganglion cells by brimonidine in rats with laser-induced chronic ocular hypertension.
WoldeMussie E; Ruiz G; Wijono M; Wheeler LA
Invest Ophthalmol Vis Sci; 2001 Nov; 42(12):2849-55. PubMed ID: 11687528
[TBL] [Abstract][Full Text] [Related]
20. [Results of argon laser treatment of 100 eyes with open-angle glaucoma (trabeculoplasty, trabeculoretraction)].
Moulin F; Haut J
J Fr Ophtalmol; 1983; 6(8-9):661-70. PubMed ID: 6687151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
